| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT01018810 Details | 2011-07-29 Interventional | 2 | 8 | Antibodies Immunoglobulins Interleukin-23 Psoriasis | The trial was terminated for several reasons, including complexities in development of
LY2525623, but not because of safety concerns Study BDAD was terminated early due to non-safety related complexities in LY2525623 development. Numerical summaries and statistical comparisons for the 8 patients enrolled are not appropriate and may be scientifically/clinically misleading. | |||
| NCT00839059 Details | 2011-07-29 Interventional | 1 | 14 | Lenalidomide Leukemia Leukemia, Myelo… Leukemia, Myelo… Acute Myeloid L… | Results of an interim analysis and a hardly ongoing enrolment in the last 10 months in all six
participating centres - | |||
| NCT00613964 Details | 2011-07-22 Interventional | 4 | - | Diuretics Sodium Potassiu… Heart Failure Renal Insuffici… Renal Failure | - - | |||
| NCT00523458 Details | 2011-07-22 Interventional | 4 | 5 | Efavirenz Nevirapine Tuberculosis HIV Infections | A delay in protocol approval and approval of laboratory sites in Salvador, Brazil left too
little time for completion of enrollment into the study. - | |||
| NCT00483275 2006-006205-83 Details | 2011-07-21 Interventional | 4 | - | Alfacalcidol Hydroxycholecal… Renal Insuffici… Renal Insuffici… Accidental Fall… Aged Chronic Renal I… | No final agreement with sponsor - | |||
| NCT00670813 2005-003196-21 Details | 2011-07-20 Interventional | 2 | - | Modafinil Depression Sleep Deprivati… | - - | |||
| NCT00003561 Details | 2011-07-20 Interventional | 2 | - | Interferon-alph… Interferons Sargramostim Leukemia Leukemia, Myelo… Leukemia, Myelo… Leukemia, Myelo… | - - | |||
| NCT00002778 Details | 2011-07-20 Interventional | 2 | - | Sargramostim Leukemia Leukemia, Myelo… Leukemia, Myelo… | subject accrual and data analysis is completed. - | |||
| NCT00730665 Details | 2011-07-14 Interventional | 2 | 81 | Esomeprazole Gastroesophagea… Gastroesophagea… | This study has been placed on clinical hold by the sponsor due to operational reasons. - | |||
| NCT00412750 NCT00376389 Details | 2011-07-13 Interventional | 3 | 159 | Peginterferon a… Telbivudine Hepatitis Hepatitis A Hepatitis B | Enrollment stopped for safety issues - | |||
| NCT00743886 Details | 2011-07-12 Interventional | 2/3 | - | Mitogens MCL Tear | - - | |||
| NCT00118300 Details | 2011-07-08 Interventional | 1 | 0 | Capecitabine Endometrial Neo… Uterine Cervica… Vaginal Neoplas… Cervical Cancer Endometrial Can… Ovarian Cancer Vaginal Cancer | Competing studies - | |||
| NCT00844727 Details | 2011-07-06 Interventional | 2/3 | 38 | Rofecoxib Colorectal Neop… Nasopharyngeal … Duodenal Polypo… | Drug withdrawal - | |||
| NCT00590538 Details | 2011-06-30 Interventional | 1/2 | 9 | 4-phenylbutyric… Genistein Cystic Fibrosis Fibrosis | 12/15/2008 Voluntarily placed on inactive status-requested by the PI No analysis was completed on data collected; More clinically efficacious compounds have been identified which suggested that completion of this study might not be as critical as when initially proposed; therefore, the study was terminated by PI. | |||
| NCT00518193 Details | 2011-06-30 Interventional | 2 | 44 | Cetuximab Uterine Cervica… Cervix Cancer | high rate of medullar aplasia with infectious troubles. - | |||
| NCT00376259 Details | 2011-06-30 Interventional | 3 | 43 | Adefovir Adefovir dipivo… Telbivudine Hepatitis Hepatitis A Hepatitis B | The study was not completed as planned and was terminated early with agreement from the
European Medicines Agency (EMEA) The study was not completed as planned and was terminated early with agreement from the European Medicines Agency (EMEA). | |||
| NCT00988507 Details | 2011-06-28 Interventional | 2 | - | Artesunate Ferroquine Malaria Plasmodium Falc… | Company decision to modify the ferroquine development strategy; discontinuation not due to
safety or activity unexpected findings - | |||
| NCT01096745 Details | 2011-06-23 Interventional | 2 | - | Cisplatin Gemcitabine Biliary Tract N… Locally Advance… Metastatic Bili… | Planning for randomized phase III trial for this issue. - | |||
| NCT00806910 Details | 2011-06-23 Interventional | 4 | 0 | Conivaptan Heart Failure | Sponsor support withdrawn - | |||
| NCT00532285 Details | 2011-06-23 Interventional | 2 | 44 | Albumin-Bound P… Gemcitabine Paclitaxel Breast Neoplasm… Breast Cancer | terminated - |